119 related articles for article (PubMed ID: 32700682)
1. Silencing of lncRNA PART1 inhibits proliferation, invasion and migration of breast cancer cells and promotes the efficacy of cisplatin in breast cancer cells.
Zhang L; Zhang J; Ni C
Gen Physiol Biophys; 2020 Jul; 39(4):343-354. PubMed ID: 32700682
[TBL] [Abstract][Full Text] [Related]
2. LncRNA LOXL1-AS1 inhibited cell proliferation, migration and invasion as well as induced apoptosis in breast cancer via regulating miR-143-3p.
Li GH; Yu JH; Yang B; Gong FC; Zhang KW
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10400-10409. PubMed ID: 31841194
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA PART1 predicts a poor prognosis and promotes the malignant progression of pancreatic cancer by sponging miR-122.
Hu X; Zhang L; Tian J; Ma J
World J Surg Oncol; 2021 Apr; 19(1):122. PubMed ID: 33865422
[TBL] [Abstract][Full Text] [Related]
4. Downregulated Long Noncoding RNA PART1 Inhibits Proliferation and Promotes Apoptosis in Bladder Cancer.
Hu X; Feng H; Huang H; Gu W; Fang Q; Xie Y; Qin C; Hu X
Technol Cancer Res Treat; 2019 Jan; 18():1533033819846638. PubMed ID: 31311442
[TBL] [Abstract][Full Text] [Related]
5.
Yang H; Zhang X; Zhu L; Yang Y; Yin X
DNA Cell Biol; 2021 Jun; 40(6):821-832. PubMed ID: 34030482
[TBL] [Abstract][Full Text] [Related]
6. LncRNA PART1 regulates colorectal cancer via targeting miR-150-5p/miR-520h/CTNNB1 and activating Wnt/β-catenin pathway.
Zhou T; Wu L; Ma N; Tang F; Zong Z; Chen S
Int J Biochem Cell Biol; 2020 Jan; 118():105637. PubMed ID: 31669140
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
Song R; Zhang J; Huang J; Hai T
Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
[TBL] [Abstract][Full Text] [Related]
8. LncRNA PART1 modulates chondrocyte proliferation, apoptosis, and extracellular matrix degradation in osteoarthritis via regulating miR-373-3p/SOX4 axis.
Zhu YJ; Jiang DM
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8175-8185. PubMed ID: 31646607
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of long chain non-coding RNA CTBP1-AS in regulation of invasion and migration of breast cancer cells.
Cui HB; Geng CZ
J Biol Regul Homeost Agents; 2019 May-Jun,; 33(3):773-785. PubMed ID: 31165609
[TBL] [Abstract][Full Text] [Related]
10. The Role of Tumor-related LncRNA PART1 in Cancer.
Chen J; Meng E; Lin Y; Shen Y; Hu C; Zhou G; Yuan C
Curr Pharm Des; 2021; 27(40):4152-4159. PubMed ID: 34225608
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion.
Lou KX; Li ZH; Wang P; Liu Z; Chen Y; Wang XL; Cui HX
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1358-1365. PubMed ID: 29565494
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
13. LncRNA GAS5 regulates the proliferation, migration, invasion and apoptosis of brain glioma cells through targeting GSTM3 expression. The effect of LncRNA GAS5 on glioma cells.
Li G; Cai Y; Wang C; Huang M; Chen J
J Neurooncol; 2019 Jul; 143(3):525-536. PubMed ID: 31172354
[TBL] [Abstract][Full Text] [Related]
14. The novel long non‑coding RNA PRNCR1‑2 is involved in breast cancer cell proliferation, migration, invasion and cell cycle progression.
Pang D; Hu Q; Lan X; Lin Y; Duan H; Cao S; Lin Y; Li L; Peng F; Pan F
Mol Med Rep; 2019 Mar; 19(3):1824-1832. PubMed ID: 30592261
[TBL] [Abstract][Full Text] [Related]
15. miRNA-106a Promotes Breast Cancer Cell Proliferation, Clonogenicity, Migration, and Invasion Through Inhibiting Apoptosis and Chemosensitivity.
You F; Luan H; Sun D; Cui T; Ding P; Tang H; Sun D
DNA Cell Biol; 2019 Feb; 38(2):198-207. PubMed ID: 30570350
[TBL] [Abstract][Full Text] [Related]
16. SNHG14 silencing suppresses the progression and promotes cisplatin sensitivity in non-small cell lung cancer.
Jiao P; Hou J; Yao M; Wu J; Ren G
Biomed Pharmacother; 2019 Sep; 117():109164. PubMed ID: 31252267
[TBL] [Abstract][Full Text] [Related]
17. lncRNA PART1 Promotes Breast Cancer Cell Progression by Directly Targeting miR-4516.
Wang Z; Xu R
Cancer Manag Res; 2020; 12():7753-7760. PubMed ID: 32922076
[TBL] [Abstract][Full Text] [Related]
18. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
Shi H; Pu J; Zhou XL; Ning YY; Bai C
Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
[TBL] [Abstract][Full Text] [Related]
19. LncRNA34977 promotes the proliferation, migration, and invasion and inhibits the apoptosis of canine mammary tumors by regulating the expression of miR-8881/ELAVL4.
Lu B; Zhu Y; Wu J; Qiu H; Wang J; Ma Z; Jia K
Funct Integr Genomics; 2023 Jan; 23(1):31. PubMed ID: 36604379
[TBL] [Abstract][Full Text] [Related]
20. Effects of cisplatin on the proliferation, invasion and apoptosis of breast cancer cells following β‑catenin silencing.
Zhu X; Feng J; Fu W; Shu X; Wan X; Liu J
Int J Mol Med; 2020 Jun; 45(6):1838-1850. PubMed ID: 32186756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
